Teradyne Inc (TER) Valuation

The valuation assessment reveals significant concerns. The primary tool in the framework is a DCF analysis, and the GoodMoat Target of $89.64 implies the current price of $323.36 is at a substantial premium. According to the GoodMoat Margin of Safety bands, this represents a negative MoS far exceeding 100%, placing it firmly in the 'Unfavourable' category. A value investor seeks a margin of safety of at least 20%, which is entirely absent here. The forward P/E of 91.4 is exceptionally high, especially for a company with a 17.4% profit margin. While revenue growth is strong at 43.9% YoY, the P/E is not justified by sustainable profitability metrics, and such a multiple typically prices in near-perfect, high-growth execution for years. Furthermore, the Free Cash Flow Yield of 0.9% is very low, translating to a P/FCF multiple over 110x, which is not favourable under any growth profile. Compared to the framework's valuation checks, Teradyne fails on nearly all counts: no margin of safety, extreme multiples, and a low FCF yield. The stock is priced as a hyper-growth story, but its profitability and cash generation levels do not support the current valuation, making it expensive relative to its underlying quality.